Inventor

CHANDER MADHAVI C

US15 patents

⚠️ This page may combine multiple inventors who share the name “CHANDER MADHAVI C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NAPRO BIOTHERAPEUTICS INC

13 patents

US5675025AOct 7, 1997

Paclitaxel synthesis from precursor compounds and methods of producing the same

NAPRO BIOTHERAPEUTICS INC23 citations92

US6281368B1Aug 28, 2001

Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III

NAPRO BIOTHERAPEUTICS INC25 citations91

US6495705B2Dec 17, 2002

Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes

NAPRO BIOTHERAPEUTICS INC14 citations84

US6143902ANov 7, 2000

C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof

NAPRO BIOTHERAPEUTICS INC6 citations73

US6136999AOct 24, 2000

C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof

NAPRO BIOTHERAPEUTICS INC7 citations73

US6133462AOct 17, 2000

C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor

NAPRO BIOTHERAPEUTICS INC17 citations73

US6066749AMay 23, 2000

Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis

NAPRO BIOTHERAPEUTICS INC13 citations72

US6048990AApr 11, 2000

Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position

NAPRO BIOTHERAPEUTICS INC14 citations72

US5914411AJun 22, 1999

Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position

NAPRO BIOTHERAPEUTICS INC10 citations72

US6448417B1Sep 10, 2002

Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III

NAPRO BIOTHERAPEUTICS INC3 citations61

TAPESTRY PHARMACEUTICALS INC

2 patents

US7153946B2Dec 26, 2006

Molecular conjugates for use in treatment of cancer

TAPESTRY PHARMACEUTICALS INC33 citations90

US6825166B2Nov 30, 2004

Molecular conjugates for use in treatment of cancer

TAPESTRY PHARMACEUTICALS INC15 citations81

CHANDER MADHAVI C

NAPRO BIOTHERAPEUTICS INC

Paclitaxel synthesis from precursor compounds and methods of producing the same

Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III

Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes

C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof

C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof

C-7 CBZ baccatin III and production method therefor

Intermediate for use in docetaxel synthesis and production method therefor

Paclitaxel synthesis from precursor compounds and methods of producing the same

C-2&#39; hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor

Method for conversion of C-2&#39;-O-protected-10-hydroxy taxol to c-2&#39;-O-protected taxol:useful intermediates in paclitaxel synthesis

Method for selective acylation of C-2&#39;-O-protected-10-hydroxy-taxol at the C-10 position

Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position

Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III

TAPESTRY PHARMACEUTICALS INC

Molecular conjugates for use in treatment of cancer

Molecular conjugates for use in treatment of cancer

C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor

Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis

Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position